Romero-González RJ, Cuéllar-Aguirre C, Díaz-Hernández L

Language: Spanish
References: 27
Page: 26-32
PDF size: 161.47 Kb.

ABSTRACT

Introduction: In Mexico, several institutions perform routine blood cross-matching (CM) before a cholecystectomy to ensure one unit of erythrocyte concentrate (EC, 230-330 ml) in case of a bleeding event (450 ml) in case of a bleeding event requiring urgent transfusion. Some studies do not support this practice. Objective: To evaluate the probability of requiring a transfusion and the need of a CM prior to a cholecystectomy. Material and methods: A retrospective study was done of patients who underwent cholecystectomy. A comparison was performed between cases that required, or did not require a blood transfusion. Reasons for transfusion and cost analysis were included. Results: Of the 503 evaluated cholecystectomies, four (0.8%) required transfusion and only one (0.2%) was considered urgent. Of the four patients who required transfusion, three (75%) underwent laparoscopic cholecystectomy and all four (100%) were obese, required longer surgical time and hospital length of stay. The cost of performing 503 routine CM in our institution was $53,212 dollars. Conclusion: CM tests prior to a cholecystectomy should be done selectively. Each institution should have its own guidelines to ensure safe, quick and less expensive protocols.

REFERENCES

1. Bonilla-Zavala R. Importancia de las pruebas cruzadas y de la búsqueda de anticuerpos. Rev Med Inst Mex Seguro Soc. 2006; 44: 43-46.

2. Chaudhary R, Agarwal N. Safety of type and screen method compared to conventional antigloblulin crossmatch procedures for compatibility testing in Indian setting. Asian J Transfus Sci. 2011; 5: 157-159.

3. Alfonso-Valdéz Y, Bencomo-Hernández A. Procedimientos para la detección e identificación de anticuerpos eritrocitarios. Rev Cubana Hematol Inmunol Hemoter. 2001; 17: 98-107.

4. Chow EY. The impact of the type and screen test policy on hospital transfusion practice. Hong Kong Med J. 1999; 5: 275-279.

5. Norma Oficial Mexicana. NOM-253-SSA1-2012, 9.5.6.5. Para disposición de sangre humana y sus componentes con fines terapéuticos.

6. Guía de referencia rápida. Diagnóstico y tratamiento de colecistitis y colelitiasis. IMSS. ISBN 978-607-8270-71-2.

7. Agha RA, Borrelli MR, Vella-Baldacchino M, Thavayogan R, Orgill DP; STROCSS Group. The STROCSS statement: strengthening the reporting of cohort studies in surgery. Int J Surg. 2017; 46: 198-202.

8. Lin JS, Chen YJ, Tzeng CH, Lyou JY, Lee CH. Revisiting of preoperative blood ordering policy—a single institute’s experience in Taiwan. J Chin Med Assoc. 2006; 69: 507-511.

9. Rouault C, Gruenhagen J. Reorganization of blood ordering practices. Transfusion. 1978; 18: 448-453.

10. Davis SP, Barrasso C, Ness PM. Maximizing the benefits of type and screen by continued surveillance of transfusion practice. Am J Med Technol. 1983; 49: 579-582.

11. Bhutia SG, Srinivasan K, Ananthakrishnan N, Jayanthi S, Ravishankar M. Blood utilization in elective surgery—requirements, ordering and transfusion practices. Natl Med J India. 1997; 10: 164-168.

12. Oliveira A, Fleming R, Galvão M. Utilização de sangue em cirurgias programadas. Acta Med Port. 2006; 19: 357-362.

13. Turienzo-Santos EO, Rodríguez-García JI, Trelles-Martín A, Aza-González J. Integral management of the process of laparoscopic cholecystectomy. Cir Esp. 2006; 80: 385-394.

14. Usal H, Nabagiez J, Sayad P, Ferzli GS. Cost effectiveness of routine type and screen testing before laparoscopic cholecystectomy. Surg Endosc. 1999; 13: 146-147.

15. Ransom SB, Fundaro G, Dombrowski MP. Cost-effectiveness of routine blood type and screen testing for cesarean section. J Reprod Med. 1999; 44: 592-594.

16. Ransom SB, Fundaro G, Dombrowski MP. The cost-effectiveness of routine type and screen admission testing for expected vaginal delivery. Obstet Gynecol. 1998; 92: 493-495.

17. Haanschoten MC, van Straten AH, Verstappen F, van de Kerkhof D, van Zundert AA, Soliman Hamad MA. Reducing the immediate availability of red blood cells in cardiac surgery, a single-centre experience. Neth Heart J. 2015; 23: 28-32.

18. Jayaranee S, Prathiba R, Vasanthi N, Lopez CG. An analysis of blood utilization for elective surgery in a tertiary medical centre in Malaysia. Malays J Pathol. 2002; 24: 59-66.

19. Saxena S, Nelson JM, Osby M, Shah M, Kempf R, Shulman IA. Ensuring timely completion of type and screen testing and the verification of ABO/Rh status for elective surgical patients. Arch Pathol Lab Med. 2007; 131: 576-581.

20. Mead JH, Anthony CD, Sattler M. Hemotherapy in elective surgery: an incidence report, review of the literature, and alternatives for guideline appraisal. Am J Clin Pathol. 1980; 74: 223-227.

21. Lim EJ, Lopez CG, Veera SN, Menaka N, Aminah A. Efficiency of blood usage for elective surgery in the University Hospital Kuala Lumpur. Malays J Pathol. 1996; 18: 107-112.

22. Chaiken BP, Holmquest DL. Patient safety: modifying processes to eliminate medical errors. Nurs Outlook. 2003; 51: S21-S24.

23. Siegler JE, Patel NN, Dine CJ. Prioritizing paperwork over patient care: why can’t we do both? J Grad Med Educ. 2015; 7: 16-18.

24. Dutton RP, Shih D, Edelman BB, Hess J, Scalea TM. Safety of uncrossmatched type-O red cells for resuscitation from hemorrhagic shock. J Trauma. 2005; 59: 1445-1449.

25. Inaba K, Teixeira PG, Shulman I, Nelson J, Lee J, Salim A, et al. The impact of uncross-matched blood transfusion on the need for massive transfusion and mortality: analysis of 5,166 uncross-matched units. J Trauma. 2008; 65: 1222-1226.

26. Strandenes G, Berséus O, Cap AP, Hervig T, Reade M, Prat N, et al. Low titer group O whole blood in emergency situations. Shock. 2014; 41 Suppl 1: 70-75.

27. Yazer MH, Jackson B, Sperry JL, Alarcon L, Triulzi DJ, Murdock AD. Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg. 2016; 81: 21-26.